ODYY
Odyssey Health, Inc.
OTC Markets OTCQBUSDEQUITY
DELAYED
Last price
0.01
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
0.01
Prev close
0.01
Day high
0.01
Day low
0.01
Volume
10.00K
Market cap
—
P/E (TTM)
—
52W range
0.00 – 0.13
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
+42.86%
+39.1%
3M
-50.00%
-53.1%
6M
-81.82%
-92.9%
YTD
-69.70%
-82.0%
1Y
-71.43%
-91.4%
3Y
-90.48%
-164.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | — | $0 | $0 | $0 | — |
| Operating revenue | — | $0 | $0 | $0 | — |
| Research & development | — | $55.17K | $201.33K | $1.32M | — |
| Selling, general & admin | — | $2.08M | $4.94M | $6.79M | — |
| Total operating expense | — | $2.14M | $5.14M | $8.11M | — |
| Operating income | — | -$2.14M | -$5.14M | -$8.11M | — |
| Net interest income | — | -$518.48K | -$614.08K | -$836.29K | — |
| Pre-tax income | — | -$842.32K | -$5.92M | -$8.44M | — |
| Net income | — | -$842.32K | -$5.92M | -$8.44M | — |
| Net income to common | — | -$905.77K | -$5.92M | -$8.44M | — |
| Basic EPS | -0.02 | -0.01 | -0.07 | -0.09 | -100.0% |
| Diluted EPS | -0.02 | -0.01 | -0.07 | -0.09 | -100.0% |
| EBIT | — | -$323.84K | -$5.31M | -$7.61M | — |
| EBITDA | — | -$322.30K | -$5.30M | -$7.61M | — |
| Basic shares | 104.71M | 97.06M | 82.68M | 89.00M | +7.9% |
| Diluted shares | 104.71M | 97.06M | 82.68M | 89.00M | +7.9% |
| Line item | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $2.38K | $36.87K | $72.53K | -93.5% |
| Cash & short-term investments | $2.38K | $36.87K | $72.53K | -93.5% |
| Total current assets | $56.94K | $405.89K | $526.42K | -86.0% |
| Property, plant & equipment | — | — | $0 | — |
| Goodwill & intangibles | $0 | $49.91K | $43.26K | -100.0% |
| Total assets | $586.15K | $455.79K | $569.68K | +28.6% |
| Total current liabilities | $5.92M | $6.61M | $5.21M | -10.5% |
| Current debt | $1.65M | $2.14M | $1.53M | -23.2% |
| Total debt | $1.65M | $2.14M | $1.53M | -23.2% |
| Total liabilities | $5.92M | $6.61M | $5.21M | -10.5% |
| Retained earnings | -$61.00M | -$60.10M | -$54.18M | -1.5% |
| Shareholder equity | -$5.33M | -$6.16M | -$4.64M | +13.4% |
| Working capital | -$5.86M | -$6.21M | -$4.69M | +5.5% |
| Net tangible assets | -$5.33M | -$6.21M | -$4.69M | +14.1% |
| Shares issued | 96.71M | 79.07M | 77.86M | +22.3% |
| Line item | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|
| Net income | -$842.32K | -$5.92M | -$8.44M | +85.8% |
| Depreciation & amortisation | $1.54K | $3.42K | $2.37K | -55.0% |
| Change in working capital | $514.87K | $916.81K | $639.36K | -43.8% |
| Operating cash flow | -$1.22M | -$1.47M | -$3.18M | +17.6% |
| Capital expenditure | — | -$10.06K | -$45.22K | — |
| Investing cash flow | $1.00M | -$10.06K | -$45.22K | +10,039.4% |
| Financing cash flow | $180.72K | $1.45M | $2.74M | -87.5% |
| Free cash flow | -$1.22M | -$1.48M | -$3.22M | +18.2% |
| End cash position | $2.38K | $36.87K | $72.53K | -93.5% |
| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-04-30 | 2025-01-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — |
| Research & development | — | — | — | $0 | $0 | — |
| Selling, general & admin | $297.55K | $181.94K | $303.19K | $129.06K | $156.59K | +63.5% |
| Total operating expense | $297.55K | $181.94K | $303.19K | $129.06K | $156.59K | +63.5% |
| Operating income | -$297.55K | -$181.94K | -$303.19K | -$129.06K | -$156.59K | -63.5% |
| Net interest income | -$527.55K | -$2.99M | -$602.70K | -$61.40K | -$63.43K | +82.3% |
| Pre-tax income | $765.89K | -$3.60M | -$483.45K | -$251.74K | -$220.13K | +121.3% |
| Net income | $765.89K | -$3.60M | -$483.45K | -$251.74K | -$220.13K | +121.3% |
| Net income to common | $765.89K | -$3.60M | -$483.45K | -$251.74K | -$220.13K | +121.3% |
| Basic EPS | 0.01 | -0.03 | 0.00 | 0.00 | 0.00 | +133.3% |
| Diluted EPS | 0.01 | -0.03 | 0.00 | 0.00 | 0.00 | +133.3% |
| EBIT | $1.29M | -$3.19M | -$388.11K | -$190.35K | -$156.69K | +140.6% |
| EBITDA | $1.29M | -$3.19M | -$388.11K | -$190.35K | -$156.69K | +140.6% |
| Basic shares | 108.03M | 107.85M | 106.04M | 104.71M | 104.71M | +0.2% |
| Diluted shares | 186.67M | 107.85M | 106.04M | 104.71M | 104.71M | +73.1% |
| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-04-30 | 2025-01-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $297.81K | $616.33K | $25.59K | $3.19K | $7.19K | -51.7% |
| Cash & short-term investments | $297.81K | $616.33K | $25.59K | $3.19K | $7.19K | -51.7% |
| Total current assets | $373.78K | $721.30K | $143.62K | $67.36K | $108.36K | -48.2% |
| Total assets | $373.78K | $721.30K | $143.62K | $164.51K | $266.87K | -48.2% |
| Total current liabilities | $10.12M | $11.32M | $7.30M | $6.87M | $6.73M | -10.5% |
| Current debt | $2.64M | $2.27M | $1.97M | $1.98M | $1.97M | +16.4% |
| Total debt | $2.64M | $2.27M | $1.97M | $1.98M | $1.97M | +16.4% |
| Total liabilities | $10.12M | $11.32M | $7.30M | $6.87M | $6.73M | -10.5% |
| Retained earnings | -$66.07M | -$66.83M | -$63.23M | -$62.49M | -$62.24M | +1.1% |
| Shareholder equity | -$9.75M | -$10.60M | -$7.16M | -$6.70M | -$6.46M | +8.0% |
| Working capital | -$9.75M | -$10.60M | -$7.16M | -$6.80M | -$6.62M | +8.0% |
| Net tangible assets | -$9.75M | -$10.60M | -$7.16M | -$6.70M | -$6.46M | +8.0% |
| Shares issued | 100.97M | 99.85M | 99.85M | 96.71M | 96.71M | +1.1% |
| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-04-30 | 2025-01-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $765.89K | -$3.60M | -$483.45K | -$251.74K | -$220.13K | +121.3% |
| Depreciation & amortisation | — | — | — | $0 | $0 | — |
| Stock-based compensation | $0 | $0 | $0 | $11.78K | $36.13K | — |
| Change in working capital | $110.37K | $31.17K | $73.15K | $162.97K | $125.29K | +254.1% |
| Operating cash flow | -$318.52K | -$284.26K | -$284.00K | -$4.00K | -$46.68K | -12.1% |
| Investing cash flow | — | — | — | $0 | — | — |
| Financing cash flow | $0 | $875.00K | $290.50K | $0 | $0 | -100.0% |
| Free cash flow | -$318.52K | -$284.26K | -$284.00K | -$4.00K | -$46.68K | -12.1% |
| End cash position | $297.81K | $616.33K | $25.59K | $3.19K | $7.19K | -51.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.01
+0.00% from price
SMA 20
0.01
+14.94% from price
SMA 50
0.01
+24.38% from price
SMA 100
0.03
-61.77% from price
SMA 200
0.04
-75.12% from price
EMA 12
0.01
+4.03% from price
EMA 26
0.01
+9.15% from price
EMA 50
0.01
-16.82% from price
RSI (14)
56.9
Neutral
MACD (12,26,9)
0.00
Hist 0.00
ATR (14)
0.00
14.29% of price
Realised vol 30D
249.6%
Annualised
Bollinger upper
0.01
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.01 vs 0.04
Trend bias
Below 200
-75.12%
Risk profile
Beta vs SPY
2.66
More volatile than market
Correlation to SPY
0.13
Largely independent
Realised vol 30D
249.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-96.2%
Peak to trough
Max drawdown 5Y
-99.3%
Peak to trough
ATR 14
0.00
14.29% of price
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.